Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling path...

por Ibrahim, Sherif Abdelaziz, Gadalla, Ramy, El-Ghonaimy, Eslam A., Samir, Omnia, Mohamed, Hossam Taha, Hassan, Hebatallah, Greve, Burkhard, El-Shinawi, Mohamed, Mohamed, Mona Mostafa, Götte, Martin
Publicado 2017